Adherence to pharmacological therapy in patients with hansen’s disease

Detalhes bibliográficos
Autor(a) principal: Oliveira, Josiéle Gomes de
Data de Publicação: 2022
Outros Autores: Oliveira, Isabella Alcantara de, Valério, Danielle Conceição de Barros Costa, Santos, Débora Aparecida da Silva, Alves, Rauni Jandé Roama, Goulart, Letícia Silveira
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Baiana de Saúde Pública (Online)
Texto Completo: https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3312
Resumo: Hansen’s disease, a chronic infectious disease caused by Mycobacterium leprae, is considered a major public health issue. Adherence to pharmacological therapy contributes to the patient’s quality of life and to interrupting the disease transmission chain. Hence, this study analyzes adherence to multidrug therapy in patients with Hansen’s disease treated at a specialized care service in Rondonópolis, Mato Grosso, Brazil. A quantitative, descriptive research was carried out with 63 patients diagnosed with Hansen’s disease and treated at the Specialized Care Service of the municipality of Rondonópolis. Adherence was analyzed using the Morisky-Green test. A total of 31 (49.2%) patients were classified as adherent to treatment. The lowest frequency of adherence was observed in women, aged 51 to 59 years, white, family income ? 2 minimum wages, with up to eight years of schooling, without partners, and with a sewage system in their homes. Statistical difference was observed for the variables gender (p=0.036), detection mode (p=0.008), and clinical form (p=0.028). Results showed low adherence to multidrug therapy. Women, patients with referral detection or collective exams, with undetermined clinical form, tuberculoid or Lepromatous leprosy, are less adherent to polychemotherapy. The findings indicate the need to adopt measures that seek to promote better adherence to pharmacological therapy among patients with Hansen’s disease.
id IBICT-3_2c43e86f2afa32b4d60cf0a46972cebf
oai_identifier_str oai:ojs.pkp.sfu.ca:article/3312
network_acronym_str IBICT-3
network_name_str Revista Baiana de Saúde Pública (Online)
repository_id_str
spelling Adherence to pharmacological therapy in patients with hansen’s diseaseAdherencia a la terapia farmacológica en pacientes con lepraAdesão à terapia farmacológica em pacientes com hanseníaseHanseníaseAdesão à medicaçãoSaúdehanseníasesaúde coletivaepidemiologiaLepraCumplimiento de la medicaciónSaludHansen’s diseaseMedication adherenceHealthHansen’s disease, a chronic infectious disease caused by Mycobacterium leprae, is considered a major public health issue. Adherence to pharmacological therapy contributes to the patient’s quality of life and to interrupting the disease transmission chain. Hence, this study analyzes adherence to multidrug therapy in patients with Hansen’s disease treated at a specialized care service in Rondonópolis, Mato Grosso, Brazil. A quantitative, descriptive research was carried out with 63 patients diagnosed with Hansen’s disease and treated at the Specialized Care Service of the municipality of Rondonópolis. Adherence was analyzed using the Morisky-Green test. A total of 31 (49.2%) patients were classified as adherent to treatment. The lowest frequency of adherence was observed in women, aged 51 to 59 years, white, family income ? 2 minimum wages, with up to eight years of schooling, without partners, and with a sewage system in their homes. Statistical difference was observed for the variables gender (p=0.036), detection mode (p=0.008), and clinical form (p=0.028). Results showed low adherence to multidrug therapy. Women, patients with referral detection or collective exams, with undetermined clinical form, tuberculoid or Lepromatous leprosy, are less adherent to polychemotherapy. The findings indicate the need to adopt measures that seek to promote better adherence to pharmacological therapy among patients with Hansen’s disease.La lepra es una enfermedad infecciosa crónica causada por Mycobacterium leprae y considerada un grave problema de salud pública. La adherencia a la terapia farmacológica contribuye a la calidad de vida del paciente y a la interrupción de la cadena de transmisión de la enfermedad. Este estudio tuvo como objetivo analizar la adherencia a la poliquimioterapia en pacientes con lepra seguidos en un servicio de atención especializado en la ciudad de Rondonópolis, en Mato Grosso (Brasil). Se trata de un estudio descriptivo, de tipo cuantitativo. Participaron en la investigación 63 pacientes diagnosticados de lepra, seguidos en el Servicio de Atención Especializado del Municipio de Rondonópolis. Para analizar la adherencia se utilizó la prueba de Morisky-Green. Un total de 31 (49,2%) pacientes fueron clasificados como adherentes al tratamiento. La menor frecuencia de adherencia se observó en mujeres, en el grupo de edad de entre 51 y 59 años, de color autodeclarado blanco, renta familiar mayor o igual a 2 salarios mínimos, con nivel de educación hasta ocho años, sin pareja y que tenían red de alcantarillado en sus hogares. Hubo diferencia estadística para la variable sexo (p = 0,036), modo de detección (p = 0,008) y forma clínica (p = 0,028). Los resultados indicaron una baja adherencia a la poliquimioterapia. Las mujeres, los pacientes con modo de detección por derivación o exámenes colectivos, con forma clínica indeterminada, tuberculoide o virchowiana fueron los menos adherentes a la poliquimioterapia. Los resultados indican la necesidad de adoptar medidas que busquen promover una mejor aceptación de la terapia farmacológica entre los pacientes con lepra.A hanseníase é uma doença infecciosa crônica causada pelo Mycobacterium leprae, considerada um grave problema de saúde pública. A adesão à terapia farmacológica contribui para a qualidade de vida do paciente e para a interrupção da cadeia de transmissão da doença. Este trabalho objetivou analisar a adesão à poliquimioterapia em pacientes com hanseníase acompanhados em um serviço de atendimento especializado do município de Rondonópolis (MT). Trata-se de um estudo descritivo de abordagem quantitativa. Participaram da pesquisa 63 pacientes com diagnóstico de hanseníase, acompanhados no Serviço de Atendimento Especializado do Município de Rondonópolis. Para analisar a adesão, utilizou-se o teste de Morisky-Green. Foram classificados como aderentes ao tratamento 31 pacientes (49,2%) no total. As menores frequências de adesão foram observadas em mulheres, na faixa etária de 51 a 59 anos, de cor autodeclarada branca, renda familiar superior ou igual a dois salários mínimos, com até oito anos de estudo, sem companheiros e que possuíam rede de esgoto em suas residências. Observou-se diferença estatística para as variáveis sexo (p = 0,036), modo de detecção (p = 0,008) e forma clínica (p = 0,028). Os resultados indicaram baixa adesão à poliquimioterapia. Mulheres, pacientes com modo de detecção do tipo encaminhamento ou exames de coletividade, com forma clínica indeterminada, tuberculoide ou virchowiana são menos aderentes à poliquimioterapia. Os resultados indicam a necessidade de adoção de medidas que busquem promover melhor aceitação à terapia farmacológica entre os pacientes com hanseníase.SESAB2022-07-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/331210.22278/2318-2660.2021.v45.n2.a3312Revista Baiana de Saúde Pública; v. 45 n. 2 (2021); 37-492318-26600100-023310.22278/2318-2660.2021.v45.N2reponame:Revista Baiana de Saúde Pública (Online)instname:Secretaria da Saúde do Estado da Bahia (Sesab)instacron:IBICTporhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3312/3002Copyright (c) 2021 Revista Baiana de Saúde Públicainfo:eu-repo/semantics/openAccessOliveira, Josiéle Gomes deOliveira, Isabella Alcantara deValério, Danielle Conceição de Barros CostaSantos, Débora Aparecida da SilvaAlves, Rauni Jandé RoamaGoulart, Letícia Silveira2023-02-13T16:43:51Zoai:ojs.pkp.sfu.ca:article/3312Revistahttps://rbsp.sesab.ba.gov.br/index.php/rbspPUBhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/oai||saude.revista@saude.ba.gov.br|| rbsp.saude@saude.ba.gov.br2318-26600100-0233opendoar:2024-03-06T12:58:13.636979Revista Baiana de Saúde Pública (Online) - Secretaria da Saúde do Estado da Bahia (Sesab)false
dc.title.none.fl_str_mv Adherence to pharmacological therapy in patients with hansen’s disease
Adherencia a la terapia farmacológica en pacientes con lepra
Adesão à terapia farmacológica em pacientes com hanseníase
title Adherence to pharmacological therapy in patients with hansen’s disease
spellingShingle Adherence to pharmacological therapy in patients with hansen’s disease
Oliveira, Josiéle Gomes de
Hanseníase
Adesão à medicação
Saúde
hanseníase
saúde coletiva
epidemiologia
Lepra
Cumplimiento de la medicación
Salud
Hansen’s disease
Medication adherence
Health
title_short Adherence to pharmacological therapy in patients with hansen’s disease
title_full Adherence to pharmacological therapy in patients with hansen’s disease
title_fullStr Adherence to pharmacological therapy in patients with hansen’s disease
title_full_unstemmed Adherence to pharmacological therapy in patients with hansen’s disease
title_sort Adherence to pharmacological therapy in patients with hansen’s disease
author Oliveira, Josiéle Gomes de
author_facet Oliveira, Josiéle Gomes de
Oliveira, Isabella Alcantara de
Valério, Danielle Conceição de Barros Costa
Santos, Débora Aparecida da Silva
Alves, Rauni Jandé Roama
Goulart, Letícia Silveira
author_role author
author2 Oliveira, Isabella Alcantara de
Valério, Danielle Conceição de Barros Costa
Santos, Débora Aparecida da Silva
Alves, Rauni Jandé Roama
Goulart, Letícia Silveira
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Josiéle Gomes de
Oliveira, Isabella Alcantara de
Valério, Danielle Conceição de Barros Costa
Santos, Débora Aparecida da Silva
Alves, Rauni Jandé Roama
Goulart, Letícia Silveira
dc.subject.por.fl_str_mv Hanseníase
Adesão à medicação
Saúde
hanseníase
saúde coletiva
epidemiologia
Lepra
Cumplimiento de la medicación
Salud
Hansen’s disease
Medication adherence
Health
topic Hanseníase
Adesão à medicação
Saúde
hanseníase
saúde coletiva
epidemiologia
Lepra
Cumplimiento de la medicación
Salud
Hansen’s disease
Medication adherence
Health
description Hansen’s disease, a chronic infectious disease caused by Mycobacterium leprae, is considered a major public health issue. Adherence to pharmacological therapy contributes to the patient’s quality of life and to interrupting the disease transmission chain. Hence, this study analyzes adherence to multidrug therapy in patients with Hansen’s disease treated at a specialized care service in Rondonópolis, Mato Grosso, Brazil. A quantitative, descriptive research was carried out with 63 patients diagnosed with Hansen’s disease and treated at the Specialized Care Service of the municipality of Rondonópolis. Adherence was analyzed using the Morisky-Green test. A total of 31 (49.2%) patients were classified as adherent to treatment. The lowest frequency of adherence was observed in women, aged 51 to 59 years, white, family income ? 2 minimum wages, with up to eight years of schooling, without partners, and with a sewage system in their homes. Statistical difference was observed for the variables gender (p=0.036), detection mode (p=0.008), and clinical form (p=0.028). Results showed low adherence to multidrug therapy. Women, patients with referral detection or collective exams, with undetermined clinical form, tuberculoid or Lepromatous leprosy, are less adherent to polychemotherapy. The findings indicate the need to adopt measures that seek to promote better adherence to pharmacological therapy among patients with Hansen’s disease.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3312
10.22278/2318-2660.2021.v45.n2.a3312
url https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3312
identifier_str_mv 10.22278/2318-2660.2021.v45.n2.a3312
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3312/3002
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Baiana de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Baiana de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SESAB
publisher.none.fl_str_mv SESAB
dc.source.none.fl_str_mv Revista Baiana de Saúde Pública; v. 45 n. 2 (2021); 37-49
2318-2660
0100-0233
10.22278/2318-2660.2021.v45.N2
reponame:Revista Baiana de Saúde Pública (Online)
instname:Secretaria da Saúde do Estado da Bahia (Sesab)
instacron:IBICT
instname_str Secretaria da Saúde do Estado da Bahia (Sesab)
instacron_str IBICT
institution IBICT
reponame_str Revista Baiana de Saúde Pública (Online)
collection Revista Baiana de Saúde Pública (Online)
repository.name.fl_str_mv Revista Baiana de Saúde Pública (Online) - Secretaria da Saúde do Estado da Bahia (Sesab)
repository.mail.fl_str_mv ||saude.revista@saude.ba.gov.br|| rbsp.saude@saude.ba.gov.br
_version_ 1798948057474138112

Registros relacionados